Supplementary Figure 2 from Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice

Authors :: Michio Sata
Hirohisa Yano
Takato Ueno
Hironori Koga
Osamu Hashimoto
Mitsuhiko Abe
Hiroshi Masuda
Hideki Iwamoto
Toru Nakamura
Takuji Torimura
Kinya Inoue
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file, 82KB, Inhibitory effect of vandetanib on phosphorylation of EGFR.

Full Text Access

Tools